跳至主要内容
临床试验/CTRI/2022/05/042781
CTRI/2022/05/042781招募中3 期

Study of efficacy of Low dose vs Standard dose of Thalidomide in patients with transfusion dependent thalassemia (TDT): a non-inferiority trial

Pahuja trust for blood disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Any diagnosed patient of TDT who is between age 12-25 years
  • 2. With no current or recent (in past 6 months) of any regular specific drug therapy for hemoglobinopathy
  • 3. Records available to ascertain mean Hb, transfusion frequency and transfusion volumes recieved in preceding 12 weeks period

排除标准

  • 1. Weight less than 25 kg or more than 75 kg
  • 2. Known case with HIV, active HCV or Hepatitis B infection
  • 3. Those with any other known systemic illness or known thromboembolic phenomenon
  • 4. Current evidence of hypersplenism
  • 5. Not consenting for contraception if cohabiting
  • 6. Not willing for MTP in case get pregnant while on therapy

研究者

发起方
Pahuja trust for blood disorders

相似试验